Table 1 Patient characteristics
Variables | At the first TACE (n = 619) | At the second TACE (n = 514) |
|---|---|---|
Age (years) | 59 (52–66) | – |
Male gender | 489 (79.0) | – |
Etiology | ||
HBV/ HCV/ others | 422 (68.2)/ 90 (14.5)/ 107 (17.3) | – |
Child-Pugh class | ||
A/ B | 516 (83.4)/ 103 (16.6) | 436 (84.8)/ 78 (15.2) |
BCLC stage | ||
0/ A/ B/ C | 36 (5.8)/ 261 (42.2)/ 227 (36.7)/ 95 (15.3) | 128 (24.9)/ 174 (33.9)/ 121 (23.5)/ 91 (17.7) |
Tumor size (cm) | 3.5 (2.1–6.5) | 2.1 (1.3–4.0) |
Tumor number | ||
Unifocal/ multifocal | 334 (54.0)/ 285 (46.0) | 451 (87.7)/ 63 (12.3) |
Alpha-fetoprotein (ng/mL) | ||
≤400/ > 400 | 471 (76.1)/ 148 (23.9) | 458 (89.1)/ 56 (10.9) |
Segmental portal vein invasion | 74 (12.0) | 74 (14.4) |
Total bilirubin (mg/dL) | 0.9 (0.6–1.3) | 1.0 (0.6–1.3) |
Serum albumin (g/dL) | 3.9 (3.4–4.2) | 3.7 (3.3–4.1) |